Open for bidsGermanyGoodsAdd to pipeline

Abschluss nicht-exklusiver Rabattvereinbarungen nach §130a Abs.8 SGB V zu verschiedenen Wirkstoff-/en/-kombinationen mit jederzeitiger Abschlussmöglichkeit im Rahmen des sog. Open House-Verfahrens

AOK Nordost. Die Gesundheitskasse.(buyer)

Published: Published 28 November 2025
Deadline: Deadline: 5 December 2027 (440 days left)

See 22 live opportunities How Skim finds tenders View original notice ↗

Tender documents

Skim pulls every file the buyer attaches to this process and extracts the requirements from it.

Documents as they publish

Specification, evaluation criteria, pricing schedules and every requirement — extracted, searchable and mapped to your response.

View tender files

Overview

AOK Nordost, a German health insurance fund, is procuring non-exclusive rebate agreements under §130a Abs.8 SGB V (German Social Code Book V) for various active pharmaceutical ingredients and combinations through an Open House procedure with continuous submission opportunities until December 2027. The scope covers the conclusion of discount agreements with pharmaceutical manufacturers for multiple drugs and drug combinations on an ongoing basis.

Contracting authority

AOK Nordost. Die Gesundheitskasse.Procuring entity
22 live opportunities · 1 awarded contract
Potsdam, Germany
Authority website ↗

Find the key decision makers

The people who scope, score and sign this contract — names, roles and how to reach them.

Reveal decision makers

Lots (22)

Alfacalcidol
Apremilast
Bismutsubcitrat, Tetrcyclin und Metronidazol
Calcipotriol und Betamethason (ATC D05AX22) - ausgenommen Salben und Gele
Fertigarzneimittel Acarizax (ATC V01AA03 - Hausstaubmilben)
Fertigarzneimittel Grazax (ATC V01AA02 - Gräserpollen)
Fertigarzneimittel Itulazax (ATC V01AA05 - Baumpollen)
Fertigarzneimittel Oralair (ATC V01AA02 - Gräserpollen)
Flecainid
Glatirameracetat (in der Darreichungsform Fertigspritze)
Guanfacin
Lamivudin, Tenofovirdisoproxil und Doravirin
Lanthan (III)-carbonat
Levothyroxin-Natrium
Prednison
Rotigotin
Tafluprost
Tafluprost und Timolol
Teriparatid
Tofacitinib
Tofacitinib
Tofacitinib

Key details

Country: Germany
Status: Open for bids
Category: Goods
Procedure: Open
SME suitable: No
Published: 28 November 2025
Deadline: 5 December 2027

Classification (CPV)

Pharmaceutical products

Notice history

Every published notice in this contracting process, newest first.

Contract Notice
12 December 2025
Contract Notice
5 December 2025
Contract Notice
28 November 2025

More from AOK Nordost. Die Gesundheitskasse.

Other contracts from the same contracting authority. 22 live opportunities · 1 awarded contract on their hub.

See all their tenders →

Open for bidsGermanyGoods